Search results for "HEMATOPOIETIC STEM"

showing 10 items of 404 documents

Consequence of Histoincompatibility beyond GvH-Reaction in Cytomegalovirus Disease Associated with Allogeneic Hematopoietic Cell Transplantation: Cha…

2021

Hematopoietic cell (HC) transplantation (HCT) is the last resort to cure hematopoietic malignancies that are refractory to standard therapies. Hematoablative treatment aims at wiping out tumor cells as completely as possible to avoid leukemia/lymphoma relapse. This treatment inevitably co-depletes cells of hematopoietic cell lineages, including differentiated cells that constitute the immune system. HCT reconstitutes hematopoiesis and thus, eventually, also antiviral effector cells. In cases of an unrelated donor, that is, in allogeneic HCT, HLA-matching is performed to minimize the risk of graft-versus-host reaction and disease (GvHR/D), but a mismatch in minor histocompatibility antigens …

0301 basic medicine030106 microbiologyCytomegalovirusGraft vs Host DiseaseCD8 T cellsReviewHuman leukocyte antigengraft-versus-host disease (GvHD)MicrobiologyMinor Histocompatibility AntigensMice03 medical and health sciencesImmune systemavidityVirologyMinor histocompatibility antigenmedicineAnimalsHumansTransplantation HomologousCytotoxic T cellImmunodeficiencybusiness.industryHematopoietic Stem Cell Transplantationcytomegalovirus diseasehematopoietic reconstitutionhematopoietic cell transplantation (HCT)medicine.diseaseQR1-502Transplantationantigen presentationLeukemia030104 developmental biologyInfectious DiseasesHematologic NeoplasmsCytomegalovirus InfectionsImmunologybusinessCD8Viruses
researchProduct

Re-examining the relationship between active cytomegalovirus (CMV) infection and acute graft-versus-host disease in allogeneic stem cell transplant r…

2015

0301 basic medicineAdultGraft RejectionMaleAdolescentmedicine.medical_treatment030106 microbiologyCongenital cytomegalovirus infectionCytomegalovirusGraft vs Host DiseaseHematopoietic stem cell transplantationTherapeuticsReal-Time Polymerase Chain ReactionCohort Studies03 medical and health sciencesYoung AdultAcute graft versus host diseasemedicineHumansTransplantation HomologousYoung adultAgedRetrospective StudiesTransplantationbusiness.industryGraft SurvivalFollow up studiesHematopoietic Stem Cell TransplantationMiddle Agedmedicine.diseaseTransplantationReal-time polymerase chain reactionHematologic NeoplasmsImmunologyCytomegalovirus InfectionsFemaleStem cellbusinessFollow-Up StudiesTransplant international : official journal of the European Society for Organ Transplantation
researchProduct

Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients

2017

Abstract Background Torque Teno virus (TTV) plasma DNA load directly correlate with the level of immunosuppresion in different clinical settings. It is uncertain whether this may be the case in allogeneic hematopoietic stem cell transplant recipients (allo-HSCT). Objectives We characterized the dynamics of TTV DNAemia in patients undergoing T-cell replete allo-SCT. Study design Retrospective single-center observational study including 72 allo-HSCT patients. Plasma TTV DNA loads were quantified before initiating the conditioning regimen and at different time-points after transplant by real-time PCR. White blood cells (WBC) and absolute lymphocyte counts (ALC) were measured by flow cytometry.…

0301 basic medicineAdultMaleHomologousTorque teno virusAdolescentLymphocyteAllogeneic hematopoietic stem cell transplantation (Allo-HSCT); Immune reconstitution; Torque Teno virus (TTV); TTV DNAemia; Adolescent; Adult; Aged; DNA Virus Infections; DNA Viral; Female; Humans; Immunocompromised Host; Leukocyte Count; Male; Middle Aged; Retrospective Studies; Torque teno virus; Transplantation Homologous; Viral Load; Viremia; Young Adult; Hematopoietic Stem Cell Transplantation; Virology; Infectious Diseases030106 microbiologyTTV DNAemiaFlow cytometry03 medical and health sciencesImmunocompromised HostLeukocyte CountYoung AdultVirologyMedicineTransplantation HomologousHumansIn patientViralViremiaProspective cohort studyAgedRetrospective StudiesTorque teno virusTransplantationmedicine.diagnostic_testbusiness.industryHematopoietic Stem Cell TransplantationDNAImmune reconstitutionMiddle AgedViral LoadDNA Virus Infectionssurgical procedures operative030104 developmental biologymedicine.anatomical_structureInfectious DiseasesAllogeneic hematopoietic stem cell transplantation (Allo-HSCT); Immune reconstitution; Torque Teno virus (TTV); TTV DNAemia; Adolescent; Adult; Aged; DNA Virus Infections; DNA; Viral; Female; Humans; Immunocompromised Host; Leukocyte Count; Male; Middle Aged; Retrospective Studies; Torque teno virus; Transplantation; Homologous; Viral Load; Viremia; Young Adult; Hematopoietic Stem Cell Transplantation; Virology; Infectious DiseasesImmunologyDNA ViralAllogeneic hematopoietic stem cell transplantation (Allo-HSCT)FemaleAllogeneic hematopoietic stem cell transplantStem cellImmunocompetencebusinessTorque Teno virus (TTV)
researchProduct

Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation.

2016

Major histocompatibility complex class I polypeptide-related sequence A (MICA) is a highly polymorphic ligand of the activating NKG2D receptor on natural killer (NK) cells, γδ-T cells, and NKT cells. MICA incompatibilities have been associated with an increased graft-versus-host disease (GVHD) incidence, and the MICA-129 (met/val) dimorphism has been shown to influence NKG2D signaling in unrelated hematopoietic stem cell transplantation (uHSCT). We investigated the effect of MICA matching on survival after uHSCT. We sequenced 2172 patients and their respective donors for MICA. All patients and donors were high-resolution HLA-typed and matched for 10/10 (n = 1379), 9/10 (n = 636), or 8/10 (n…

0301 basic medicineAdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentImmunologyHematopoietic stem cell transplantationHuman leukocyte antigenMajor histocompatibility complexBiochemistryGastroenterology03 medical and health sciencesYoung Adult0302 clinical medicineInternal medicinemedicineMinor histocompatibility antigenHumansAgedPolymorphism GeneticbiologyDonor selectionbusiness.industryHistocompatibility TestingHistocompatibility Antigens Class IHematopoietic Stem Cell TransplantationCell BiologyHematologyMiddle AgedNKG2DNatural killer T cellSurvival AnalysisTissue DonorsSurgeryTransplantationstomatognathic diseases030104 developmental biologyGenetic LociMultivariate Analysisbiology.proteinFemalebusiness030215 immunologyBlood
researchProduct

Aspergilosis invasora en el paciente con enfermedad oncohematológica

2018

Invasive aspergillosis is the most common invasive fungal infection in patients with acute hematological malignancies or treated with hematopoietic stem cell transplantation due to the marked alteration of the physiological mechanisms of antifungal immunity that takes place in these situations. For this reason, antifungal prophylaxis has a relevant role in these patients. The introduction of new antifungal agents has motivated the updating of recommendations for prophylaxis and treatment in different guidelines. The objectives of this chapter are a brief review of the mechanisms of immunity against fungi, the definition of risk for developing an invasive fungal infection and an update of th…

0301 basic medicineAntifungalmedicine.drug_classbusiness.industrymedicine.medical_treatment030106 microbiologyHematopoietic stem cell transplantationAspergillosismedicine.diseaseMicrobiology03 medical and health sciencesInfectious DiseasesHematological DiseasesImmunityImmunologymedicineIn patientbusinessRevista Iberoamericana de Micología
researchProduct

HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation.

2016

Refractory or relapsed acute myeloid leukemia (AML) represents a frequent complication after allogeneic hematopoietic stem-cell transplantation (HSCT). We show herein that primary in vitro stimulation of CD45RA-selected CD4 T cells of stem-cell donors with 10/10 HLA-matched AML blasts results in expansion of cytolytic T-lymphocytes (CTL) that almost all recognize HLA-DPB1 mismatch alleles, which clinically occur in up to 80% of donor-patient pairs. Primary AML blasts were found to strongly express HLA-DPB1, whereas fibroblasts and keratinocytes used as surrogate target cells for graft-versus-host disease did express HLA-DPB1 only upon IFN-γ pre-treatment. Since patients' AML blasts are rare…

0301 basic medicineCD4-Positive T-LymphocytesCytotoxicity ImmunologicCancer ResearchAdoptive cell transferGenotypemedicine.medical_treatmentHematopoietic stem cell transplantationBiologyLymphocyte ActivationImmunotherapy Adoptive03 medical and health sciencesMice0302 clinical medicinehemic and lymphatic diseasesmedicineAnimalsHumansTransplantation HomologousAllelesHLA-DP beta-ChainsLeukemiaHematopoietic Stem Cell TransplantationMyeloid leukemiaHematologyImmunotherapymedicine.diseaseTissue DonorsTransplantationCTL*LeukemiaLeukemia Myeloid Acute030104 developmental biologyOncologyImmunologyFemaleImmunotherapyStem cell030215 immunologyLeukemia
researchProduct

Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments

2017

The complex interaction between cells undergoing transformation and the various stromal and immunological cell components of the tumor microenvironment (TME) crucially influences cancer progression and diversification, as well as endowing clinical and prognostic significance. The immunosuppression characterizing the TME depends on the recruitment and activation of different cell types including regulatory T cells, myeloid-derived suppressor cells, and tumor-associated macrophages. Less considered is the non-cellular component of the TME. Here, we focus on the extracellular matrix (ECM) regulatory activities that, within the TME, actively contribute to many aspects of tumor progression, acti…

0301 basic medicineCancer ResearchCell typeStromal cellMyeloidCarcinogenesisImmunologyBiology03 medical and health sciencesBone MarrowNeoplasmsmedicineImmune ToleranceImmunology and AllergyAnimalsHumansMyeloid-Derived Suppressor CellCarcinogenesiTumor microenvironmentAnimalMyeloid-Derived Suppressor CellsHematopoietic stem cellSPARCBone marrow nicheExtracellular matrixCell biology030104 developmental biologymedicine.anatomical_structureRegulatory myeloid suppressor cellOncologyTumor microenvironmentTumor progressionMyeloid-derived Suppressor CellBone marrow niche; Extracellular matrix; Regulatory myeloid suppressor cells; SPARC; Tumor microenvironment; Animals; Bone Marrow; Carcinogenesis; Extracellular Matrix; Humans; Immune Tolerance; Myeloid-Derived Suppressor Cells; Neoplasms; Tumor Escape; Tumor MicroenvironmentNeoplasmTumor Escapesense organsBone marrowHuman
researchProduct

2021

Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality following hematopoietic stem cell transplantation (HSCT). Measuring CMV-specific cellular immunity may improve the risk stratification and management of patients. IFN-γ ELISpot assays, based on the stimulation of peripheral blood mononuclear cells with CMV pp65 and IE-1 proteins or peptides, have been validated in clinical settings. However, it remains unclear to which extend the T-cell response to synthetic peptides reflect that mediated by full-length proteins processed by antigen-presenting cells. We compared the stimulating ability of pp65 and IE-1 proteins and corresponding overlapping peptides in 16 HSCT recip…

0301 basic medicineCellular immunityAntigen processingbusiness.industryELISPOTmedicine.medical_treatmentClinical BiochemistryCongenital cytomegalovirus infectionvirus diseasesImmunosuppressionHematopoietic stem cell transplantationmedicine.diseasePeripheral blood mononuclear cell03 medical and health sciences030104 developmental biology0302 clinical medicine030220 oncology & carcinogenesisImmunologyMedicinebusinessCD8Diagnostics
researchProduct

Recombinant Ganoderma lucidum Immunomodulatory Protein Improves the Treatment for Chemotherapy-Induced Neutropenia

2020

Ganoderma lucidum, also known as LINGZHI, has a long tradition of use in folk medicine of the Far East, which is documented in the oldest Chinese pharmacopoeia, declaring it a superior medicine. LINGZHI-8 (LZ-8) is an immunoregulatory fungal protein isolated from the fruiting body of Ganoderma lucidum. Neutropenia is a condition with an abnormally low levels of neutrophils in the blood, which is caused by numerous medical conditions or medications, such as chemotherapy. The current study demonstrated that recombinant LZ-8 (rLZ-8) from Pichia promoted the differentiation of bone marrow hematopoietic stem cells (HSCs) into granulocytes in a neutropenia mouse model induced by cyclophosphamide.…

0301 basic medicineCyclophosphamidegranulocyte-colony stimulating factorPharmacologyNeutropeniaColony stimulating factor 1 receptor03 medical and health sciences0302 clinical medicinecolony-stimulating factor 1 receptormedicineneutropeniaPharmacology (medical)rLZ-8Original ResearchPharmacologyFungal proteinbusiness.industrylcsh:RM1-950medicine.diseasehematopoietic stem cellsGranulocyte colony-stimulating factorHaematopoiesislcsh:Therapeutics. Pharmacology030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisBone marrowStem cellbusinessmedicine.drugFrontiers in Pharmacology
researchProduct

Non-cognate bystander cytolysis by clonal epitope-specific CTL lines through CD28-CD80 interaction inhibits antibody production: A potential caveat t…

2015

Abstract Adoptive transfer of virus epitope-specific CD8 T cells is an immunotherapy option to control cytomegalovirus (CMV) infection and prevent CMV organ disease in immunocompromised solid organ transplantation (SOT) and hematopoietic cell transplantation (HCT) recipients. The therapy aims at an early, selective recognition and cytolysis of infected cells for preventing viral spread in tissues with no adverse immunopathogenic side-effects by attack of uninfected bystander cells. Here we describe that virus epitope-specific, cloned T-cell lines lyse target cells that present the cognate antigenic peptide to the TCR, but simultaneously have the potential to lyse uninfected cells expressing…

0301 basic medicineCytotoxicity ImmunologicAdoptive cell transfermedicine.medical_treatmentImmunologyCytomegalovirusEpitopes T-Lymphocytechemical and pharmacologic phenomenaBiologyImmunotherapy AdoptiveEpitope03 medical and health sciencesMiceCD28 AntigensmedicineCytotoxic T cellAnimalsB-LymphocytesHematopoietic Stem Cell TransplantationCD28hemic and immune systemsImmunotherapyBystander EffectOrgan TransplantationVirologyClone CellsTransplantationCytolysis030104 developmental biologyAntibody FormationCytomegalovirus InfectionsB7-1 AntigenCD80T-Lymphocytes CytotoxicCellular immunology
researchProduct